Gene expression related to the FAK pathway was incorporated as a variable in this examination based on reports and previous research indicating that recurrence of ovarian cancer, treatment resistance, and CSCs are related to FAK activity [24, 77–80]. Here, PTK2 is linked to ovarian cancer.